Author

Peter Koch

Observed names: Koch, Peter, P Koch, P. Koch

Observed institutions: Universität Hamburg, University of Cologne, Universität Innsbruck, Johannes Gutenberg University Mainz, University of Münster, Christian-Albrechts-Universität zu Kiel, Medizinische Hochschule Hannover, Katharinenhospital, Kreiskrankenhaus Gummersbach, University Hospital Münster, University Medical Center Hamburg-Eppendorf, University Hospital Leipzig, Pius Hospital Oldenburg, University Hospital Frankfurt, Swiss Group For Clinical Cancer Research, Klinikum Passau, University Hospital Cologne, Helios Hospital Berlin-Buch, University Hospital Carl Gustav Carus, Stiftung Charité, Heinrich Heine University Düsseldorf, Martin Luther University Halle-Wittenberg, University of Göttingen, Charité – Universitätsmedizin Berlin, Ludwig-Maximilians-Universität München, Sapienza University of Rome, Leipzig University, Otto-von-Guericke-Universität Magdeburg

ORCID: 0000-0002-2556-6612

Observed ORCID: 0000-0002-2556-6612

OpenAlex ID: A5042935151

Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults

1988 · D Hoelzer, E Thiel, et al. · Blood · 596

PDF

Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study

2009 · Andreas Engert, Volker Diehl, et al. · Journal of Clinical Oncology · 499

Primary Gastrointestinal Non-Hodgkin’s Lymphoma: I. Anatomic and Histologic Distribution, Clinical Features, and Survival Data of 371 Patients Registered in the German Multicenter Study GIT NHL 01/92

2001 · Peter Koch, Francisco del Valle, et al. · Journal of Clinical Oncology · 493

Involved-Field Radiotherapy Is Equally Effective and Less Toxic Compared With Extended-Field Radiotherapy After Four Cycles of Chemotherapy in Patients With Early-Stage Unfavorable Hodgkin’s Lymphoma: Results of the HD8 Trial of the German Hodgkin’s Lymphoma Study Group

2003 · Andreas Engert, Petra Schiller, et al. · Journal of Clinical Oncology · 459

Improved outcome in adult B-cell acute lymphoblastic leukemia

1996 · D Hoelzer, WD Ludwig, et al. · Blood · 314

Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults

1984 · D Hoelzer, E Thiel, et al. · Blood · 303

PDF

Two Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Plus Extended-Field Radiotherapy Is Superior to Radiotherapy Alone in Early Favorable Hodgkin's Lymphoma: Final Results of the GHSG HD7 Trial

2007 · Andreas Engert, Jeremy Franklin, et al. · Journal of Clinical Oncology · 264

PDF

Treatment Results in Localized Primary Gastric Lymphoma: Data of Patients Registered Within the German Multicenter Study (GIT NHL 02/96)

2005 · Peter Koch, Andreas Probst, et al. · Journal of Clinical Oncology · 250

PDF

Primary Gastrointestinal Non-Hodgkin’s Lymphoma: II. Combined Surgical and Conservative or Conservative Management Only in Localized Gastric Lymphoma—Results of the Prospective German Multicenter Study GIT NHL 01/92

2001 · Peter Koch, Francisco del Valle, et al. · Journal of Clinical Oncology · 233

ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)

2012 · M. Ghielmini, U. Vitolo, et al. · Annals of Oncology · 218

PDF

Male gonadal dysfunction in patients with Hodgkin’s disease prior to treatment

2001 · U. Rueffer, K. Breuer, et al. · Annals of Oncology · 205

Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial

2014 · Karolin Behringer, Helen Goergen, et al. · The Lancet · 185

BEACOPP: An intensified chemotherapy regimen in advanced Hodgkin's disease

1997 · V. Diehl, M. Sieber, et al. · Annals of Oncology · 152

Dexa-BEAM in patients with Hodgkin's disease refractory to multidrug chemotherapy regimens: a trial of the German Hodgkin's Disease Study Group.

1994 · M G Pfreundschuh, U Rueffer, et al. · Journal of Clinical Oncology · 119

Low-Dose Radiation Is Sufficient for the Noninvolved Extended-Field Treatment in Favorable Early-Stage Hodgkin’s Disease: Long-Term Results of a Randomized Trial of Radiotherapy Alone

2001 · Eckhart Dühmke, Jeremy Franklin, et al. · Journal of Clinical Oncology · 112

14-Day Variant of the Bleomycin, Etoposide, Doxorubicin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone Regimen in Advanced-Stage Hodgkin’s Lymphoma: Results of a Pilot Study of the German Hodgkin’s Lymphoma Study Group

2003 · M. Sieber, H. Bredenfeld, et al. · Journal of Clinical Oncology · 84

Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles

2018 · Johannes C. Hellmuth, Abner Louissaint, et al. · Blood · 71

Moderate Dose Escalation for Advanced Stage Hodgkin’s Disease Using the Bleomycin, Etoposide, Adriamycin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone Scheme and Adjuvant Radiotherapy: A Study of the German Hodgkin’s Lymphoma Study Group

1998 · H. Tesch, V. Diehl, et al. · Blood · 70

Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group

2006 · B. Klimm, H.T. Eich, et al. · Annals of Oncology · 58

PDF

Operative and conservative management of primary gastric lymphoma: interim results of a German multicenter study

2000 · Normann A Willich, Gabriele Reinartz, et al. · International Journal of Radiation Oncology*Biology*Physics · 56

Parasternal mediastinal sonography: sensitivity in the detection of anterior mediastinal and subcarinal tumors

1988 · K Wernecke, R Potter, et al. · American Journal of Roentgenology · 56

Primary lymphoma of the stomach: Three-year results of a prospective multicenter study

1997 · P. Koch, B. Grothaus-Pinke, et al. · Annals of Oncology · 52

PDF

Treatment of advanced Hodgkin’s disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin’s Lymphoma Study Group HD6 trial

2004 · M. Sieber, H. Tesch, et al. · Annals of Oncology · 46

PDF

Treatment of relapsed or refractory adult acute lymphocytic leukemia

1992 · Mathias Freund, Helmut Diedrich, et al. · Cancer · 41

Clinical aspects of acute myeloid leukemias of the FAB types M3 and M4Eo

1993 · T. Haferlach, W. Gassmann, et al. · Annals of Hematology · 32

Works count: 90

Citation count: 5,361

H-index: 27

I10-index: 40